Results 51 to 60 of about 2,699 (183)

The Management of Classical Hodgkin's Lymphoma: Past, Present, and Future

open access: yesAdvances in Hematology, 2011
The management of classical Hodgkin's lymphoma (CHL) is a success story of modern multi-agent haemato-oncology. Prior to the middle of the twentieth century CHL was fatal in the majority of cases.
S. E. Richardson, C. McNamara
doaj   +1 more source

Detection of Low-Level Tumor Cells in Allergic Contact Dermatitis Induced by Mechlorethamine in Patients with Mycosis Fungoides [PDF]

open access: yes, 1996
Two patients with histologically proven mycosis fungoides, a malignancy of phenotypically mature T cells, received a topical challenge with mechlorethamine to areas of clinically uninvolved skin to exclude possible hypersensitivity reactions to this ...
Jeffrey L. Sklar   +5 more
core   +1 more source

Targeted Drug Delivery of Anticancer Agents Using C5N2 Substrate: Insights from Density Functional Theory

open access: yesChemistry
Cancer has a threatening impact on human health, and it is one of the primary causes of fatalities worldwide. Different conventional treatments have been employed to treat cancer, but their non-specific nature reduces their therapeutic efficacy.
Syeda Huda Mehdi Zaidi   +3 more
doaj   +1 more source

Mediastinal Choriocarcinoma Masquerading as Relapsed Hodgkin Lymphoma

open access: yesCase Reports in Oncology, 2011
Primary mediastinal choriocarcinoma is a rare extragonadal germ cell malignancy. We describe the first case of a patient who developed mediastinal choriocarcinoma after treatment for Hodgkin lymphoma (HL).
Selay Lam   +2 more
doaj   +1 more source

Topical Mechlorethamine Chemotherapy

open access: yesInternational Journal of Dermatology, 1984
Eric C. Vonderheid
openaire   +3 more sources

Brentuximab Vedotin‐Induced Rash Sparing CD30‐Positive Mycosis Fungoides Lesions

open access: yesJEADV Clinical Practice, Volume 5, Issue 3, Page 971-973, September 2026.
Capsule Summary ABSTRACT Brentuximab vedotin (BV) is an effective treatment for CD30‐positive lymphomas, including mycosis fungoides (MF). However, its use can be associated with various cutaneous adverse effects, including rashes. This case describes a 60‐year‐old male with stage IIB MF who developed a drug‐induced erythematous rash after three ...
Isabel Hariri   +2 more
wiley   +1 more source

Influence of cysteine on mechlorethamine - induced chromosomal aberrations in cultured human lymphocytes [PDF]

open access: yes, 1995
The aim of the present paper was to find out by in vitro chromosomal aberration test using human lymphocytes whether cysteine has anticlastogenic properties towards a well-known mutagen - mechlorethamine.
Blaszczyk, A
core  

Long‐Term Quality of Life in 1777 Persons With Hodgkin Lymphoma and 6166 Matched Comparators

open access: yesAmerican Journal of Hematology, Volume 101, Issue 7, Page 1654-1664, July 2026.
ABSTRACT Survival has improved substantially for patients with Hodgkin lymphoma (HL), but long‐term quality of life (QoL) remains incompletely understood. This was a Danish, nationwide, cross‐sectional study of QoL among persons with a diagnosis of HL matched 1:10 to general population comparators.
Sissel Johanne Godtfredsen   +13 more
wiley   +1 more source

HPLC-UV chromatograms of DNA and the mechlorethamine-crosslinked DNA duplex.

open access: yes, 2013
A: Top-strand DNA. B: Bottom-strand DNA. C: DNA duplex (denatured on the column). D: The mechlorethamine-crosslinked DNA duplex.
Pornchai Rojsitthisak (350320)   +3 more
core   +1 more source

Role of Radiotherapy in Advanced Stage Hodgkin Lymphoma With Bulky Disease: A Systematic Review and Meta‐Analysis

open access: yeseJHaem, Volume 7, Issue 3, June 2026.
ABSTRACT Background and Purpose: Hodgkin lymphoma (HL) is an uncommon malignancy predominantly affecting young adults. Chemotherapy is the main treatment, with radiotherapy used selectively in early‐stage disease. This meta‐analysis evaluates the impact of adding radiotherapy to bulky disease sites in advanced‐stage HL patients who achieve complete ...
Ahmad Masoud   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy